TAIPEI, Taiwan--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agreed to license an approved Potassium Chloride Extended ...

capsules, USP, in 600 mg (8 mEq K) and 750 mg (10 mEq K) strengths. Potassium chloride ER is indicated for the treatment of patients with hypokalemia with or without metabolic alkalosis ...

packaged in cases of POTASSIUM CHLORIDE Inj. 20 mEq, to the user level. ICU medical has received a customer complaint which states that bags of POTASSIUM CHLORIDE Inj. 20 mEq have inco ...

Glenmark Pharmaceuticals Inc., based in Mahwah, NJ, has announced a voluntary recall of 114 batches of its Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. The recall is ...

Potassium Chloride extended-release capsules USP, 8 mEq and 10 mEq had US sales of USD 75.4 million (IMS MAT June 2016).

(RTTNews) - The US Food and Drug Administration has annuonced that ICU Medical, Inc. is recalling Potassium Chloride Injection, 20 mEq and 10 mEq, citing mislabeling. The recall involves one lot ...

20 mEq bags due to incorrect overwrap labels, which state Potassium Chloride Inj. 10 mEq. Potassium Chloride Injection is indicated for the treatment of potassium deficiency, when oral replacement ...

“If the Health Care provider mistakenly calculates the patient dose using 10 mEq, the patient will receive an overdose of potassium chloride,” the company warned in its release. The lots being ...